Trials / Completed
CompletedNCT01655849
Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate The Efficacy and Safety of Z160 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 141 (actual)
- Sponsor
- Zalicus · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will compare Z160 and placebo in patients with Lumbosacral Radiculopathy for safety and efficacy for a period of 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | z160 | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2013-10-01
- Completion
- 2013-11-01
- First posted
- 2012-08-02
- Last updated
- 2013-12-12
Locations
23 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01655849. Inclusion in this directory is not an endorsement.